In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...

The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...

The once-weekly insulin analog lowered A1c as effectively as once-daily formulations in three new trials in type 2 diabetes.

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...